Discontinuation of Coverage: Xifaxan (Rifaximin)

Effective Oct. 1, 2025, NC Medicaid will no longer cover the prescription drug Xifaxan (Rifaximin).

This bulletin applies to NC Medicaid Direct and NC Medicaid Managed Care.

Effective Oct. 1, 2025, the manufacturer of Xifaxan (Rifaximin) will no longer participate in the Medicaid Drug Rebate Program which means it will not be covered by NC Medicaid. Please read below for alternative options.

Patient Assistance Program for Free Medication

Bausch Health Companies, Inc. offers a patient assistance program that may provide free medication, including Xifaxan, to eligible patients who do not have coverage under their Medicaid pharmacy benefit. If approved, patients may receive Bausch Health prescription products for up to one year. Patients may be able to reapply annually if they continue to meet eligibility requirements and have a valid prescription.

Prescribers

Prescribers with patients taking Xifaxan (Rifaximin) can complete an application to request access through the patient assistance program on the Bausch Health Companies, Inc. website. Please work with your patient to complete the application because it asks for clinical information.

Alternative Medications

If the patient assistance program is not an option, please review covered medications and available alternatives in the latest NC Medicaid Preferred Drug List.

Contact

NCTracks Call Center: 1-800-688-6696

Related Topics: